Nutriband (NASDAQ:NTRB) Shares Up 2% – What’s Next?

Nutriband Inc. (NASDAQ:NTRB) shot up 2% during mid-day trading on Tuesday . The company traded as high as $4.10 and last traded at $4.06. 4,865 shares were traded during trading, a decline of 64% from the average session volume of 13,461 shares. The stock had previously closed at $3.98.

Nutriband Price Performance

The stock has a market capitalization of $49.43 million, a price-to-earnings ratio of -1.32 and a beta of 1.92. The business’s fifty day moving average price is $4.05 and its 200-day moving average price is $5.04. The company has a debt-to-equity ratio of 0.01, a current ratio of 7.52 and a quick ratio of 7.35.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Nutriband stock. Vanguard Group Inc. grew its stake in Nutriband Inc. (NASDAQ:NTRB) by 1.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 202,738 shares of the company’s stock after purchasing an additional 3,111 shares during the quarter. Vanguard Group Inc. owned approximately 1.68% of Nutriband worth $1,429,000 at the end of the most recent reporting period. 19.70% of the stock is currently owned by institutional investors and hedge funds.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.